Stock Info Nets

Independent Financial Information Made Easy

Our AI creates

The Best Stock Graphs and Charts

Youtube Subscribe Blog GamificArt

The development of Artificial Intelligence (AI) is modifying the way investments are evaluated. We programmed an artificial intelligence (A.I.) to summarize the whole internet. Whether you’re trying to make money investing online, making financial decisions or just getting informed about Wall Street, this page is a way to get informed without reading hundred of pages. Our stock market summary graphs are produced using machine learning, an unbiased view to capture what internet is saying. Usually, the AI reads several hundred pages and summarize it to a short text and several charts.

April 27, 2023 22:13 (London Time)

Celularity

Youtube Subscribe

...

Sector: Biotechnology
Ticker: CELU
Sentiment: 0.9021
MarketCap: 99,628,000
High: 0.66 Low: 0.58

Open: 0.65 Close: 0.6 Change: -0.05

12 things an AI found about Celularity that you should know before investing.

Are looking for the most relevant information about Celularity? Investor spend a lot of time searching for information to make investment decisions in Celularity. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Celularity are: Celularity, share, price, today, Inc, Shares, A, and the most common words in the summary are: therapeutic, celularity, stock, pharmaceutical, inc, dividend, price, . One of the sentences in the summary was: Celularity currently has 165,028,879 outstanding shares.. Other searches related to this term that the …

Concept Map

...

Semantic Network

...

Stock Summary

Celularity Inc. develops placental-derived allogeneic cell therapies for the treatment of cancer, immune, and infectious diseases. The company's lead therapeutic programs include CYCART-19, an allogeney CAR-T cell.

Today's Summary

Celularity Inc. trades on the NASDAQ under the ticker symbol CELU. The beta is 0.21, so Celularitys price volatility has been lower than the market average. Celularity currently has 165,028,879 outstanding shares.

Today's News

Celularity Inc - Ordinary Shares - Class A (CELU) Stock Price Today, News, Quotes, FAQs and Fundamentals. Celularity inc - ordinary shares - class a (celu) stock price today, news, quotes, faqs and fundamentals. Celular inc - Ordinal Shares - class A market cap is $110.71M. 52-Wk high is $13.19. In May 2009ursive brill Bulk defensivepassword Sammyshown Celularity does not appear to pay any dividends at this time. The beta is 0.21, so Celularitys price volatility has been lower than the market average. Celularity Inc. trades on the NASDAQ under the ticker symbol CELU. Celularity trades today (NASDAQ: CELu) Celularity stock price per share is $0.64 today (as of Apr 26, 2023). Celularity currently has 165,028,879 outstanding shares.

Stock Profile

"Celularity Inc., a clinical-stage biotechnology company, develops off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer, immune, and infectious diseases. It operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. The company's lead therapeutic programs include CYCART-19, an allogeneic CAR-T cell for the treatment of non-Hodkin's lymphoma (NHL) and mantle cell lymphoma (MCL); CYNK-001, an allogeneic unmodified natural killer cell that is in Phase I/II clinical trial for the treatment of acute myeloid leukemia (AML); and APPL-001, a genetically modified placental-derived mesenchymal-like adherent stromal cell for the treatment of Crohn's disease. It is also developing CYCART-201 for the treatment of NHL and MCL, and human epidermal growth factor receptor 2 positive cancers; CYNK-301, a next generation chimeric antigen receptor-natural killer (CAR-NK) for treating relapse refractory AML; CYNK-302, a CAR-NK to treat non-small cell lung cancer; and pExo-001, a human postpartum placenta derived exosome product for the treatment of osteoarthritis. It also produces, sells, and licenses products that are used in surgical and wound care markets, such as Biovance, Biovance 3L, Interfyl, and Centaflex; and collects and stores stem cells from umbilical cords and placentas under the LifebankUSA brand. The company has licensing agreement with Sorrento Therapeutics, Inc. for the development and commercialization of licensed CD19 CAR-T products. The company was founded in 1998 and is based in Florham Park, New Jersey."

Keywords

How much time have you spent trying to decide whether investing in Celularity? Many investors start with the dream of being free. They expect to find on the stock market an option to have time to develop their own interests and hobbies. That is, a way to escape a 9 to 5 job. However, investment is complex and investors end up spending whole days (and nights) trying to figure out which the right stock to invest is. The dream of stock investing becomes the nightmare of facing infinity amounts of information. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Celularity are: Celularity, share, price, today, Inc, Shares, A, and the most common words in the summary are: therapeutic, celularity, stock, pharmaceutical, inc, dividend, price, . One of the sentences in the summary was: Celularity currently has 165,028,879 outstanding shares.. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #therapeutic #celularity #stock #pharmaceutical #inc #dividend #price.

Read more →

Related Results

...
December 16, 2023 8:05 (London Time)

Celularity

Celularity Inc. declared leadership position with Duke University School of Medicine; Licensing agreement with CryoCell; licensing agreement with Si…
Sector: Biotechnology
Ticker: CELU
Sentiment: 0.7506
MarketCap: 36,241,966.0
High: 0.2 Low: 0.18

Open: 0.2 Close: 0.19 Change: -0.02

Read more →
...
November 27, 2023 19:55 (London Time)

Celularity

Celularity Inc. (CELU) has 190.95 million shares outstanding. The average price target for Celularity is $1.75, which is 665.53% higher than the cur…
Sector: Biotechnology
Ticker: CELU
Sentiment: 0.9186
MarketCap: 40,767,438.0
High: 0.23 Low: 0.21

Open: 0.21 Close: 0.23 Change: 0.02

Read more →
...
December 08, 2023 10:09 (London Time)

Celularity

Celularity (NASDAQ: CELU) has experienced a challenging market with its stock reaching a low price of $0.21. Celularity stock has received a consens…
Sector: Biotechnology
Ticker: CELU
Sentiment: 0.9852
MarketCap: 40,003,645.0
High: 0.22 Low: 0.2

Open: 0.22 Close: 0.21 Change: -0.01

Read more →
...
April 27, 2023 22:13 (London Time)

Celularity

Celularity Inc. trades on the NASDAQ under the ticker symbol CELU. The beta is 0.21, so Celularitys price volatility has been lower than the market …
Sector: Biotechnology
Ticker: CELU
Sentiment: 0.9021
MarketCap: 99,628,000
High: 0.66 Low: 0.58

Open: 0.65 Close: 0.6 Change: -0.05

Read more →